Cartalax 20mg Peptides
Built for serious research environments, this peptide is prepared with the precision required for consistent, reproducible results.
Cartalax 20mg Lyophilized Peptide Vial from Peptide Scientific Labs is a sterile-ready, non-flavored research peptide bioregulator presented in a lyophilized format for controlled handling and storage. This Peptide Lyophilized Vial contains a total strength of 20mg, supporting advanced laboratory workflows that prioritize purity, consistency, and traceable quality throughout the research process.
- Each vial contains 20mg of Cartalax, enabling controlled study of peptide bioregulator characteristics, stability profiles, and analytical method validation in qualified laboratory settings.
Designed for laboratory use, the lyophilized matrix supports efficient reconstitution by qualified personnel under appropriate aseptic technique, producing a clean, uniform solution suitable for chromatographic evaluation, in vitro assay development, and formulation method exploration. Researchers can expect a dependable material profile that facilitates precise measurements, clear documentation, and repeatable outcomes across testing cycles.
Ingredients: Cartalax
Every vial is manufactured and filled in the USA within a controlled environment and supported by lot-level traceability. Each batch undergoes HPLC and LC-MS testing for identity and purity, with specifications aligned to rigorous internal standards. Packaging is completed in cleanroom conditions with tamper-evident closures to safeguard integrity from fill to fulfillment. Temperature-conscious storage and shipping practices are followed to protect material quality during transit.
Peptide Scientific Labs is committed to transparent documentation, consistent production, and dependable service so researchers can proceed with confidence. This material is intended strictly for laboratory research use only; it is not a drug, food, or cosmetic, and is not intended for human or veterinary use. Use only by qualified professionals in appropriate research facilities, following relevant regulations and safety procedures.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
- 1
- 2
- 3
- 4
- 5
Reviews (1)
Frequently Asked Questions
What is Cartalax typically studied for?
Cartalax is typically discussed in relation to cartilage metabolism, chondrocyte signaling, extracellular-matrix support, and joint-tissue models. The right tone for an FAQ is that it is studied for these pathways in research settings, not that it is an approved intervention for joint disease.
What is Cartalax?
Cartalax is a short peptide bioregulator commonly associated with cartilage-focused research. It is usually grouped with organ- or tissue-specific peptide bioregulators rather than mainstream endocrine peptides. For website copy, it should be described as a laboratory research compound aimed at cartilage and connective-tissue investigation.
What is the Khavinson peptide theory?
The Khavinson peptide theory refers to the body of work developed by Russian researcher Vladimir Khavinson and colleagues starting in the 1970s. The central idea is that short peptides — isolated from specific tissues — can act as tissue-specific bioregulators, binding directly to DNA and modulating gene expression in a way that is selective for the tissue from which they were derived.
This theory forms the scientific background for the bioregulator category of peptides, including compounds such as Epitalon, Thymalin, Prostamax, and Cartalax. The underlying mechanisms continue to be a subject of research, and all compounds listed under this category are offered for laboratory investigation only.
What are peptide bioregulators?
Peptide bioregulators are a class of short peptides — typically di-, tri-, or tetrapeptides — that are studied as tissue-specific signaling molecules. The concept originated in Russian biogerontology research, where extracts of various tissues were fractionated and the active peptide fragments isolated and characterized. Each bioregulator is associated in the research literature with a specific tissue of origin, such as thymus, pineal, prostate, or cartilage.
In research, bioregulators are investigated in the context of gene expression, tissue-specific signaling, and age-related changes in cellular function. All bioregulator products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.
How are bioregulator peptides different from hormones?
Hormones are typically larger molecules — often proteins or steroid compounds — that are secreted by specific endocrine glands and travel through the bloodstream to act on distant target tissues via dedicated receptors. Peptide bioregulators, by contrast, are very short sequences (usually 2 to 4 amino acids) and are studied as intracellular or nuclear-level regulators that interact more directly with chromatin and gene expression in the tissues from which they were originally isolated.
Functionally, hormones tend to coordinate large-scale, system-wide processes, while bioregulators are investigated as fine-grained, tissue-specific modulators. The two categories can overlap in the broader sense of signaling biology, but they are studied as distinct classes of molecules.